MiNK Therapeutics, Inc. INKT

Full chart Compare
Set alert

Price alert · INKT

All alert types
10.64 USD -0.15 (-1.39%)

Nov 4, 2026, 1:00 PM EST

10.62 Day range 11.03
8.48 52-week range 16.93
YTD
-4.57%
1 year
-16.94%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 6.50 -38.9% downside
Target (low)
4.00
Target (mean)
6.50
Target (high)
9.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 3
  • 1 month ago 4
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

INKT analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.05-0.05 – -0.05-0.15+66.7%00.0%3
Next quarter-0.06-0.07 – -0.05-0.11+45.5%00.0%2
Current year-0.26667-0.28 – -0.25-0.65+59.0%00.0%3
Next year-0.27-0.32 – -0.21-0.26667-1.3%00.0%3

Upgrades and downgrades

The latest rating changes

INKT analyst upgrades and downgrades
DateFirmActionFromTo
Nov 15, 2024BairdMaintainedOutperformOutperform
Nov 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 9, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 13, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 21, 2024HC Wainwright & Co.MaintainedBuyBuy
Aug 10, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 12, 2023HC Wainwright & Co.MaintainedBuyBuy
Apr 19, 2023HC Wainwright & Co.Reiterated—Buy
Mar 22, 2023Evercore ISI GroupMaintained—Outperform
Mar 22, 2023HC Wainwright & Co.Reiterated—Buy
Aug 10, 2022HC Wainwright & Co.Initiated—Buy
Jan 24, 2022B. Riley SecuritiesMaintained—Buy
Nov 9, 2021William BlairInitiated—Outperform
Nov 9, 2021Evercore ISI GroupInitiated—Outperform
Nov 9, 2021BairdInitiated—Outperform